Literature DB >> 31801865

Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.

Hagar Tadmor1, Melanie Greenway2, Anuj Ahuja1, Ola Orgil1, Gangling Liao2, Richard F Ambinder2, S Diane Hayward2, Meir Shamay3,2.   

Abstract

The Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded latency-associated nuclear antigen (LANA) protein functions in latently infected cells as an essential participant in KSHV genome replication and as a driver of dysregulated cell growth. In a previous study, we have identified LANA-interacting proteins using a protein array screen. Here, we explore the effect of LANA on the stability and activity of RLIM (RING finger LIM-domain-interacting protein, encoded by the RNF12 gene), a novel LANA-interacting protein identified in that protein screen. RLIM is an E3 ubiquitin ligase that leads to the ubiquitination and degradation of several transcription regulators, such as LMO2, LMO4, LHX2, LHX3, LDB1, and the telomeric protein TRF1. Expression of LANA leads to downregulation of RLIM protein levels. This LANA-mediated RLIM degradation is blocked in the presence of the proteasome inhibitor, MG132. Therefore, the interaction between LANA and RLIM could be detected in coimmunoprecipitation assay only in the presence of MG132 to prevent RLIM degradation. A RING finger mutant RLIM is resistant to LANA-mediated degradation, suggesting that LANA promotes RLIM autoubiquitination. Interestingly, we found that LANA enhanced the degradation of some RLIM substrates, such as LDB1 and LMO2, and prevented RLIM-mediated degradation of others, such as LHX3 and TRF1. We also show that transcription regulation by RLIM substrates is modulated by LANA. RLIM substrates are assembled into multiprotein transcription regulator complexes that regulate the expression of many cellular genes. Therefore, our study identified another way KSHV can modulate cellular gene expression.IMPORTANCE E3 ubiquitin ligases mark their substrates for degradation and therefore control the cellular abundance of their substrates. RLIM is an E3 ubiquitin ligase that leads to the ubiquitination and degradation of several transcription regulators, such as LMO2, LMO4, LHX2, LHX3, LDB1, and the telomeric protein TRF1. Here, we show that the Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded LANA protein enhances the ubiquitin ligase activity of RLIM, leading to enhanced RLIM autoubiquitination and degradation. Interestingly, LANA enhanced the degradation of some RLIM substrates, such as LDB1 and LMO2, and prevented RLIM-mediated degradation of others, such as LHX3 and TRF1. In agreement with protein stability of RLIM substrates, we found that LANA modulates transcription by LHX3-LDB1 complex and suggest additional ways LANA can modulate cellular gene expression. Our study adds another way a viral protein can regulate cellular protein stability, by enhancing the autoubiquitination and degradation of an E3 ubiquitin ligase.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  E3 ubiquitin ligase; Kaposi's sarcoma; Kaposi's sarcoma-associated herpesvirus; LANA; LDB1; ORF73; RLIM

Year:  2020        PMID: 31801865      PMCID: PMC7022369          DOI: 10.1128/JVI.01578-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.

Authors:  L Coscoy; D Ganem
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7.

Authors:  Mary Canning; Chris Boutell; Jane Parkinson; Roger D Everett
Journal:  J Biol Chem       Date:  2004-07-06       Impact factor: 5.157

3.  The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20.

Authors:  Noula Shembade; Nicole S Harhaj; Kislay Parvatiyar; Neal G Copeland; Nancy A Jenkins; Lydia E Matesic; Edward W Harhaj
Journal:  Nat Immunol       Date:  2008-02-03       Impact factor: 25.606

4.  Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis.

Authors:  L Coscoy; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen.

Authors:  Masahiro Fujimuro; Jianyong Liu; Jian Zhu; Hideyoshi Yokosawa; S Diane Hayward
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.

Authors:  Wuguo Chen; Isaac B Hilton; Michelle R Staudt; Christin E Burd; Dirk P Dittmer
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

7.  Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex.

Authors:  Maria Roupelieva; Samantha J Griffiths; Elisabeth Kremmer; Michael Meisterernst; Abel Viejo-Borbolla; Thomas Schulz; Jürgen Haas
Journal:  J Gen Virol       Date:  2010-01-20       Impact factor: 3.891

8.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta.

Authors:  Masahiro Fujimuro; S Diane Hayward
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains.

Authors:  Satoko Matsumura; Linda M Persson; LaiYee Wong; Angus C Wilson
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

10.  EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.

Authors:  Qi-Liang Cai; Jason S Knight; Suhbash C Verma; Philip Zald; Erle S Robertson
Journal:  PLoS Pathog       Date:  2006-10       Impact factor: 6.823

View more
  1 in total

1.  Kaposi's sarcoma-associated herpesvirus processivity factor (PF-8) recruits cellular E3 ubiquitin ligase CHFR to promote PARP1 degradation and lytic replication.

Authors:  Woo-Chang Chung; Seungrae Lee; Yejin Kim; Jong Bok Seo; Moon Jung Song
Journal:  PLoS Pathog       Date:  2021-01-28       Impact factor: 6.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.